Novel Snakebite Therapeutics Must Be Tested in Appropriate Rescue Models to Robustly Assess Their Preclinical Efficacy

In the field of antivenom research, development, and manufacture, it is often advised to follow the World Health Organization’s (WHO) guidelines for the production, control, and regulation of snake antivenom immunoglobulins, which recommend the use of preincubation assays to assess the efficacy of s...

Descripción completa

Detalles Bibliográficos
Autores principales: Knudsen, Cecilie, Casewell, Nicholas R., Lomonte, Bruno, Gutiérrez, José María, Vaiyapuri, Sakthivel, Laustsen, Andreas H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551497/
https://www.ncbi.nlm.nih.gov/pubmed/32824899
http://dx.doi.org/10.3390/toxins12090528

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7551497/
https://www.ncbi.nlm.nih.gov/pubmed/32824899
http://dx.doi.org/10.3390/toxins12090528

Ejemplares similares